SEC Form 3/A · accession 0000899243-19-003444
Nightstar Therapeutics plc · NITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owners
Syncona Portfolio Ltd
10% Owner
Syncona Holdings Ltd
10% Owner
Syncona Ltd
10% Owner
Syncona Investment Management Ltd
10% Owner
Period of report
Jan 1, 2019
Accepted (ET)
Feb 13, 2019 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711675
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | holding | — | — | — | 13,203,922 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of 11,203,922 ordinary shares and 2,000,000 American Depository Share ("ADS") held directly by Syncona Portfolio Limited. Each ADS represents one ordinary share, nominal value 0.01 GBP per share, of the Issuer.
- F2The shares are owned directly by Syncona Portfolio Limited ("Syncona Portfolio") and indirectly by Syncona Holdings Limited ("Syncona Holdings") and Syncona Limited ("Syncona Limited"). Syncona Portfolio is a wholly owned subsidiary of Syncona Holdings, and Syncona Holdings is a wholly controlled subsidiary of Syncona Limited ("Syncona Limited"), a publicly-listed company. Investment and voting decisions with respect to these shares are made by Syncona Portfolio, acting upon the recommendation of an investment committee of Syncona Investment Management Limited, also a subsidiary of Syncona Holdings. Each of these entities disclaims beneficial ownership except to the extent of its pecuniary interest therein, if any.
Remarks
This Form 3/A amends the Form 3 filed on January 2, 2019 for the sole purpose of including Syncona Investment Management Limited as an additional reporting person.